Cav1 appears to have a significant role in murine adipocyte metabolism, and disruption of the gene leads to severe hypertriglyceridemia, insulin resistance and adipocyte abnormalities, which are all features that are consistent with human partial lipodystrophy [7-9]. The gene discussed is CAV1; the disease is partial lipodystrophy.